Biomark Diagnostics Inc. Share Price Canadian Securities Exchange
Equities
BUX
CA09073K1084
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 CAD | 0.00% | -6.67% | +9.80% |
Sales 2022 | 0.04 0.06 3.67 | Sales 2023 | 0.15 0.21 12.81 | Capitalization | 15.37M 21.03M 1.28B |
---|---|---|---|---|---|
Net income 2022 | -1M -1.37M -83.43M | Net income 2023 | -1M -1.37M -83.43M | EV / Sales 2022 | 39,22,62,031 x |
Net Debt 2022 | 1.58M 2.17M 132M | Net Debt 2023 | 1.58M 2.16M 132M | EV / Sales 2023 | 11,04,15,720 x |
P/E ratio 2022 |
-9.98
x | P/E ratio 2023 |
-8.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.76% |
1 week | -6.67% | ||
Current month | -1.75% | ||
1 month | -6.67% | ||
3 months | +1.82% | ||
Current year | +9.80% |
Managers | Title | Age | Since |
---|---|---|---|
Rashid Maula Bux
FOU | Founder | - | 19/14/19 |
Guoyu Huang
DFI | Director of Finance/CFO | - | 15/17/15 |
Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rashid Maula Bux
FOU | Founder | - | 19/14/19 |
Bram Ramjiawan
BRD | Director/Board Member | - | 11/14/11 |
Brian Cheng
CTO | Chief Tech/Sci/R&D Officer | - | 11/14/11 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 0.28 | 0.00% | 1,500 |
02/24/02 | 0.28 | 0.00% | 4,400 |
01/24/01 | 0.28 | -1.75% | 2,050 |
30/24/30 | 0.285 | -1.72% | 2,000 |
29/24/29 | 0.29 | -3.33% | 10,000 |
Delayed Quote Canadian Securities Exchange, May 04, 2024 at 12:22 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-16.10% | 11.41B | |
-30.20% | 2.3B | |
-14.31% | 2.16B | |
-26.03% | 1.56B | |
+36.95% | 1.19B | |
-2.40% | 760M | |
-19.00% | 506M | |
-38.57% | 444M | |
+13.72% | 339M |
- Stock Market
- Equities
- 20B Stock
- BUX Stock